The Foundation of the Consortium of Multiple Sclerosis Centers was gifted $100,000 by EMD Serono for its nursing scholarship ...
The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life ...
Erratum: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, ...
D.A.B. is a consultant for N of One/QIAGEN, and Tango Therapeutics; is a founder and shareholder in Xsphera Biosciences; has received honoraria from Merck, H3 Biomedicine/Esai, EMD Serono ...
Further confirmatory data will be necessary to maintain its approval in the US, where it will be co-marketed by EMD Serono, German Merck’s US biopharma business, and Pfizer. The drug was ...
Medpage Today on MSN9d
Some Cancers Occur More Frequently in Multiple Sclerosis PatientsSome cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback